p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins

Ana Montero‐Calle(Instituto de Salud Carlos III), Rodrigo Barderas(Instituto de Salud Carlos III), José M. Pingarrón(Universidad Complutense de Madrid), Susana Campuzano(Universidad Complutense de Madrid), Rebeca M. Torrente‐Rodríguez(Universidad Complutense de Madrid), Rodrigo Sanz(Hospital Clínico San Carlos), Jana Dziaková(Hospital Clínico San Carlos), María Garranzo‐Asensio(Universidad Complutense de Madrid), María Jesús Fernández‐Aceñero(Hospital Clínico San Carlos), Víctor Ruiz‐Valdepeñas Montiel(Universidad Complutense de Madrid), Carmen Povés(Hospital Clínico San Carlos), Cristina Díaz del Arco(Universidad Complutense de Madrid)
Cancers
March 31, 2023
Cited by 23


Related Papers